Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a fully-integrated biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections announced ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
A familiar compound found in everyday foods may hold unexpected potential in the fight against antibiotic resistance.
Ionis Pharmaceuticals, Inc. partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority ...
Discover 25 facts too weird to be in a textbook! From glass brains to skinless sharks, these bizarre scientific and ...
Scientists at Stanford University have discovered that DRT3, a unique defense system found in bacteria, creates DNA to ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a new imaging method, known as RF-SIRF, that ...
A system once tied to DNA organization in cyanobacteria has evolved into a structure that shapes the cell itself. This shift ...
Hosted on MSN
DNA replication made simple for bio students
From the first unzip of the double helix to the final joining of DNA fragments, replication is a carefully coordinated process. Understanding it helps explain how life preserves its genetic code with ...
Retrons adapted from E. coli enable genome editing in 15 diverse bacterial species, expanding recombineering tools across major microbial phyla.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results